Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Valvular Heart Disease

  Free Subscription


Articles published in Clin Cardiol

Retrieve available abstracts of 47 articles:
HTML format



Single Articles


    June 2026
  1. EINI P, Serpoush H, Rezayee M, Kassulke M, et al
    "Diagnostic Performance of Artificial Intelligence in Evaluating Tricuspid Regurgitation: A Systematic Review and Meta-Analysis".
    Clin Cardiol. 2026;49:e70366.
    PubMed     Abstract available



  2. Correction to "Prognostic Value of HALP Score in Rheumatic Mitral Stenosis: A Long-Term Follow-up Study".
    Clin Cardiol. 2026;49:e70361.
    PubMed    


    May 2026
  3. TALHA M, Gul S, Khan MF
    Reconsidering the Prognostic Role of the HALP Score in Rheumatic Mitral Stenosis.
    Clin Cardiol. 2026;49:e70334.
    PubMed    


    April 2026
  4. KAYA AF, Ayhan G, Can V, Ozbek E, et al
    Prognostic Value of HALP Score in Rheumatic Mitral Stenosis: A Long-Term Follow-up Study.
    Clin Cardiol. 2026;49:e70287.
    PubMed     Abstract available


  5. TAHIR I, Shahbaz H
    "Loop Diuretics in Severe Aortic Stenosis: A Marker of Disease Severity, Not a Mortality Driver".
    Clin Cardiol. 2026;49:e70306.
    PubMed    


  6. GBREEL MI, Badran AS, Hassan M, Balata M, et al
    Cerebral Embolic Protection Devices (CEPDs) During Transcatheter Aortic Valve Implantation (TAVI): A Meta-Analysis of Randomized Controlled Trials.
    Clin Cardiol. 2026;49:e70309.
    PubMed     Abstract available


  7. YILMAZ O, Unlu S, Seckin O
    Methodological Considerations on the Prognostic Value of HALP Score in Rheumatic Mitral Stenosis.
    Clin Cardiol. 2026;49:e70327.
    PubMed    


  8. TALHA M, Khan SH, Ullah A
    Methodological Considerations in Assessing HALP Score as a Prognostic Marker in Rheumatic Mitral Stenosis.
    Clin Cardiol. 2026;49:e70326.
    PubMed    


  9. BUTT SA
    Prognostic Value of HALP Score in Rheumatic Mitral Stenosis: A Long-Term Follow-Up Study.
    Clin Cardiol. 2026;49:e70324.
    PubMed    


    March 2026
  10. GAO YP, Fan YT, Cheng XQ, Huang PN, et al
    Incremental Value of NT-proBNP Over HCM-AF Score in Risk Stratification for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.
    Clin Cardiol. 2026;49:e70276.
    PubMed     Abstract available


    January 2026
  11. MIYAZAWA M, Imamura T
    Loop Diuretic Therapy in Severe Aortic Stenosis: Marker or Mediator of Adverse Outcomes?
    Clin Cardiol. 2026;49:e70264.
    PubMed    


    December 2025
  12. MAEDER MT, Breuss A, Appert S, Wildermuth S, et al
    Loop Diuretic Therapy in Severe Aortic Stenosis: Marker of Organ Congestion, Unfavorable Hemodynamics, and Increased Post-Valve Replacement Mortality.
    Clin Cardiol. 2025;48:e70225.
    PubMed     Abstract available


    August 2025
  13. ESCOLAR CONESA A, Esteve-Pastor MA, Roldan V, Soler Espejo E, et al
    Evaluation of the Presence of Native Valvular Disease in Patients With Atrial Fibrillation Using the EHRA (Evaluated Heartvalves, Rheumatic, or Artificial) Classification.
    Clin Cardiol. 2025;48:e70172.
    PubMed     Abstract available


    April 2025
  14. TAVAKOLI K, Mohammadi NSH, Bahiraie P, Saeidi S, et al
    Short-Term, Mid-Term, and Long-Term Outcomes of Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expanding Valves: A Meta-Analysis of Randomized Controlled Trials.
    Clin Cardiol. 2025;48:e70134.
    PubMed     Abstract available


    March 2025
  15. CAO X, Huang R, Geng H, Liu H, et al
    A Clinical Study of Precision Chemoablation for Hypertrophic Obstructive Cardiomyopathy Without Large Interventricular Septal Branches.
    Clin Cardiol. 2025;48:e70095.
    PubMed     Abstract available


  16. DUAN X, Qu L, Chen H
    The Prognostic Value of Platelet-Albumin-Bilirubin Score in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Clin Cardiol. 2025;48:e70100.
    PubMed     Abstract available


  17. DIAZ-AROCUTIPA C, Benites-Moya CJ, Torres-Valencia J, Mehta A, et al
    Urgent Transcatheter Mitral Edge-to-Edge Repair Is Associated With Worse in-Hospital Outcomes: A Nationwide Analysis.
    Clin Cardiol. 2025;48:e70067.
    PubMed     Abstract available


  18. KHAN FU, Khan MAUH, Khan MA, Khan S, et al
    The Prognostic Value of Platelet-Albumin-Bilirubin Score in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Clin Cardiol. 2025;48:e70119.
    PubMed    


  19. ZHANG R, Zhu C, Chen S, Tian F, et al
    Exercise-Based Cardiac Rehabilitation for Patients After Heart Valve Surgery: A Systematic Review and Re-Evaluation With Evidence Mapping Study.
    Clin Cardiol. 2025;48:e70117.
    PubMed     Abstract available


  20. SABERIAN P, Contreras R, Gurram A, Nasrollahizadeh A, et al
    Clinical Outcomes and Prognostic Implications of TAVR in Patients With Active Cancer: A Meta-Analysis.
    Clin Cardiol. 2025;48:e70121.
    PubMed     Abstract available


    February 2025
  21. CHAMBERS J, Shah BN, Garbi M, Campbell B, et al
    Management of Echocardiography Requests for the Detection and Follow-Up of Heart Valve Disease: A Consensus Statement From the British Heart Valve Society.
    Clin Cardiol. 2025;48:e70099.
    PubMed     Abstract available


    December 2024
  22. GROGER M, Felbel D, Paukovitsch M, Schneider LM, et al
    Insulin-Like Growth Factor Binding Protein 2 Predicts Right Ventricular Reverse Remodeling and Improvement of Concomitant Tricuspid Regurgitation After Transcatheter Edge-to-Edge Mitral Valve Repair.
    Clin Cardiol. 2024;47:e70048.
    PubMed     Abstract available


  23. TADIC M, Schneider L, Nita N, Felbel D, et al
    The Impact of Preprocedural Blood Pressure on Outcome After M-TEER: The Paradox or Something Else?
    Clin Cardiol. 2024;47:e70062.
    PubMed     Abstract available


    November 2024
  24. WOLFES J, Alba FT, Kaleschke G, Vormbrock J, et al
    Pacemaker Implantation for Low-Grade Conduction Abnormalities After Balloon-Expandable Transcatheter Aortic Valve Implantation.
    Clin Cardiol. 2024;47:e70028.
    PubMed     Abstract available


    October 2024
  25. MANZOOR I, Mansoor M
    Comparing Transcatheter and Surgical Mitral Valve Repair in Functional Mitral Regurgitation: Insights From a Real-World Analysis and Future Research Directions.
    Clin Cardiol. 2024;47:e70015.
    PubMed    


    August 2024
  26. FALLAHTAFTI P, Soleimani H, Ebrahimi P, Ghaseminejad-Raeini A, et al
    Comparative Analysis of PCI Strategies in Aortic Stenosis Patients Undergoing TAVI: A Systematic Review and Network Meta-Analysis.
    Clin Cardiol. 2024;47:e24324.
    PubMed     Abstract available


    July 2024
  27. TANG X, Fan W
    The Association Between Late Gadolinium Enhancement by Cardiac Magnetic Resonance and Ventricular Arrhythmia in Patients With Mitral Valve Prolapse: A Systematic Review and Meta-Analysis.
    Clin Cardiol. 2024;47:e24316.
    PubMed     Abstract available


  28. HOU J, Sun Y, Wang H, Zhang L, et al
    Papillary Muscle Infarction by Cardiac MRI in Patients With Mitral Regurgitation.
    Clin Cardiol. 2024;47:e24312.
    PubMed     Abstract available


  29. WANG X, Ma Y, Liu Z, Zhu L, et al
    Comparison of Outcomes of Edge-to-Edge Mitral Valve Repair Versus Surgical Mitral Valve Repair for Functional Mitral Regurgitation.
    Clin Cardiol. 2024;47:e24313.
    PubMed     Abstract available


    May 2024
  30. JENAB Y, Nourian S, Hosseini Mohammadi NS, Mohseni-Badalabadi R, et al
    Complications of transcatheter paravalvular leak device closure of mitral valve: An updated review of the literature and a rare case presentation.
    Clin Cardiol. 2024;47:e24272.
    PubMed     Abstract available


  31. DIAZ-AROCUTIPA C, Moreno G, Vicent L
    Impact of valvular surgery according to frailty risk in patients with infective endocarditis.
    Clin Cardiol. 2024;47:e24268.
    PubMed     Abstract available


    March 2024
  32. INOUE N, Ohtani H, Morikawa S, Takayama Y, et al
    Risk of supranormal left ventricular ejection fraction in patients with aortic stenosis.
    Clin Cardiol. 2024;47:e24255.
    PubMed     Abstract available


    February 2024
  33. ZANGIABADIAN M, Soltani K, Gholinejad Y, Yahya R, et al
    Predictors of pacemaker requirement in patients with implantable loop recorder and unexplained syncope: A systematic review and meta-analysis.
    Clin Cardiol. 2024;47:e24221.
    PubMed     Abstract available


  34. WERNER P, Winter M, Muller M, Zierfuss B, et al
    Femoral vessel complications after transfemoral TAVR-A contemporary sonography-based assessment of 480 patients with third-generation transcatheter valves.
    Clin Cardiol. 2024;47:e24197.
    PubMed     Abstract available


  35. YUE Y, Wu X, Guan X, Wu X, et al
    The prognostic value of the visually assessed time difference between mitral valve and tricuspid valve opening score for patients with heart failure with mildly reduced ejection fraction.
    Clin Cardiol. 2024;47:10.
    PubMed     Abstract available


  36. HE YG, Dong Y, Yang SH, Yang F, et al
    Short time effects of two radiofrequency ablation methods on hypertrophic obstructive cardiomyopathy.
    Clin Cardiol. 2024;47:e24217.
    PubMed     Abstract available


    January 2024
  37. SAWAN MA, Prabakaran S, D'Souza M, Behbahani-Nejad O, et al
    A systematic review of present and future pharmaco-structural therapies for hypertrophic cardiomyopathy.
    Clin Cardiol. 2024;47:e24207.
    PubMed     Abstract available


  38. SRINIVASAN A, Wong F, Wang B
    Transcatheter aortic valve replacement: Past, present, and future.
    Clin Cardiol. 2024;47:e24209.
    PubMed     Abstract available


    December 2023
  39. HE CJ, Zhu CY, Fan HY, Qian YZ, et al
    Low T3 syndrome predicts more adverse events in patients with hypertrophic cardiomyopathy.
    Clin Cardiol. 2023;46:1569-1577.
    PubMed     Abstract available


    November 2023
  40. NEVEU A, Aghezzaf S, Oger E, L'official G, et al
    Primary mitral regurgitation: Toward a better quantification on left ventricular consequences.
    Clin Cardiol. 2023 Nov 10. doi: 10.1002/clc.24190.
    PubMed     Abstract available


  41. HOSSEINPOUR A, Gupta R
    Outcomes of renin-angiotensin inhibitors following transcatheter aortic valve implantation.
    Clin Cardiol. 2023 Nov 7. doi: 10.1002/clc.24187.
    PubMed    


    September 2023
  42. SAGER P, Rusch A, Weber L, Breuss A, et al
    ECG left ventricular hypertrophy in aortic stenosis: Relationship with cardiac structure, invasive hemodynamics, and long-term mortality.
    Clin Cardiol. 2023 Sep 23. doi: 10.1002/clc.24155.
    PubMed     Abstract available


    July 2023
  43. HOU J, Sun Y, Wang H, Zhang L, et al
    Non-contrast cardiac computed tomography-derived mitral annular calcification scores in mitral valve disease.
    Clin Cardiol. 2023 Jul 28. doi: 10.1002/clc.24110.
    PubMed     Abstract available


  44. DIAZ-AROCUTIPA C, Saucedo-Chinchay J, Mamas MA
    Prognostic role of CA-125 in patients undergoing transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Clin Cardiol. 2023 Jul 17. doi: 10.1002/clc.24064.
    PubMed     Abstract available


    June 2023
  45. LI J, Wei X
    Outcomes and predictors of patients with moderate or severe functional mitral regurgitation and nonischemic dilated cardiomyopathy.
    Clin Cardiol. 2023 Jun 15. doi: 10.1002/clc.24067.
    PubMed     Abstract available


    April 2023
  46. ZHANG J, Yang Y, Jia L, Su J, et al
    Anticoagulation therapy and clinical outcomes following transcatheter mitral valve repair for patients with mitral regurgitation: A meta-analysis.
    Clin Cardiol. 2023 Apr 10. doi: 10.1002/clc.24017.
    PubMed     Abstract available


    March 2023
  47. MIZERA L, Rath D, Schreieck J, Seizer P, et al
    Deceleration capacity of heart rate predicts 1-year mortality in patients undergoing transcatheter edge-to-edge mitral valve repair.
    Clin Cardiol. 2023 Mar 22. doi: 10.1002/clc.24007.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Valvular Heart Disease is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum